Passage Bio, Inc.

NasdaqGS:PASG Rapport sur les actions

Capitalisation boursière : US$39.5m

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Passage Bio Gestion

Gestion contrôle des critères 1/4

Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.

Informations clés

Will Chou

Directeur général

US$1.4m

Rémunération totale

Pourcentage du salaire du PDG41.4%
Durée du mandat du directeur général1.9yrs
Propriété du PDGn/a
Durée moyenne d'occupation des postes de direction1.2yrs
Durée moyenne du mandat des membres du conseil d'administration3.5yrs

Mises à jour récentes de la gestion

Recent updates

Is Passage Bio (NASDAQ:PASG) In A Good Position To Deliver On Growth Plans?

Sep 24
Is Passage Bio (NASDAQ:PASG) In A Good Position To Deliver On Growth Plans?

Is Passage Bio (NASDAQ:PASG) In A Good Position To Deliver On Growth Plans?

Jun 11
Is Passage Bio (NASDAQ:PASG) In A Good Position To Deliver On Growth Plans?

We're Keeping An Eye On Passage Bio's (NASDAQ:PASG) Cash Burn Rate

Feb 27
We're Keeping An Eye On Passage Bio's (NASDAQ:PASG) Cash Burn Rate

Is Passage Bio (NASDAQ:PASG) In A Good Position To Deliver On Growth Plans?

Nov 13
Is Passage Bio (NASDAQ:PASG) In A Good Position To Deliver On Growth Plans?

We Think Passage Bio (NASDAQ:PASG) Needs To Drive Business Growth Carefully

Jun 23
We Think Passage Bio (NASDAQ:PASG) Needs To Drive Business Growth Carefully

Is Passage Bio (NASDAQ:PASG) In A Good Position To Deliver On Growth Plans?

Nov 13
Is Passage Bio (NASDAQ:PASG) In A Good Position To Deliver On Growth Plans?

Passage appoints William Chou CEO

Oct 10

Passage Bio GAAP EPS of -$0.73 beats by $0.09

Aug 04

We're A Little Worried About Passage Bio's (NASDAQ:PASG) Cash Burn Rate

Jun 03
We're A Little Worried About Passage Bio's (NASDAQ:PASG) Cash Burn Rate

Passage Bio: Worth Keeping An Eye On

Apr 11

Will Passage Bio (NASDAQ:PASG) Spend Its Cash Wisely?

Dec 15
Will Passage Bio (NASDAQ:PASG) Spend Its Cash Wisely?

Passage Bio (NASDAQ:PASG) Is In A Good Position To Deliver On Growth Plans

Aug 19
Passage Bio (NASDAQ:PASG) Is In A Good Position To Deliver On Growth Plans

Passage Bio: Price Reduced, But Without Data, Does Not Look Convincing

Jun 06

Passage Bio partners with InformedDNA to offer counseling, testing for early dementia

May 03

We're Hopeful That Passage Bio (NASDAQ:PASG) Will Use Its Cash Wisely

Mar 08
We're Hopeful That Passage Bio (NASDAQ:PASG) Will Use Its Cash Wisely

Do Institutions Own Passage Bio, Inc. (NASDAQ:PASG) Shares?

Feb 01
Do Institutions Own Passage Bio, Inc. (NASDAQ:PASG) Shares?

Passage Bio on go with PBGM01 gene therapy trial in the U.S.

Jan 04

Need To Know: Passage Bio, Inc. (NASDAQ:PASG) Insiders Have Been Buying Shares

Dec 28
Need To Know: Passage Bio, Inc. (NASDAQ:PASG) Insiders Have Been Buying Shares

U.K. authorizes Passage Bio's PBGM01 trial

Dec 10

Passage Bio (PASG) Investor Presentation - Slideshow

Nov 16

Passage Bio EPS beats by $0.13

Nov 10

Passage Bio’s PBKR03 nabs Orphan drug tag and accelerated review status for Krabbe disease

Oct 28

Analyse de la rémunération des PDG

Comment la rémunération de Will Chou a-t-elle évolué par rapport aux bénéfices de Passage Bio?
DateRémunération totaleSalaireBénéfices de l'entreprise
Jun 30 2024n/an/a

-US$77m

Mar 31 2024n/an/a

-US$84m

Dec 31 2023US$1mUS$599k

-US$102m

Sep 30 2023n/an/a

-US$112m

Jun 30 2023n/an/a

-US$112m

Mar 31 2023n/an/a

-US$128m

Dec 31 2022US$1mUS$112k

-US$136m

Rémunération vs marché: La rémunération totale de Will ($USD 1.45M ) est supérieure à la moyenne des entreprises de taille similaire sur le marché US ($USD 681.57K ).

Rémunération et revenus: La rémunération de Will a augmenté alors que l'entreprise n'est pas rentable.


PDG

Will Chou (51 yo)

1.9yrs

Titularisation

US$1,448,546

Compensation

Dr. William Chou, MD, also known as Will, has been the Chief Executive Officer and Director of Passage Bio, Inc. from October 10, 2022 and serves as its President. Dr. Chou is an accomplished executive wit...


Équipe de direction

NomPositionTitularisationCompensationPropriété
William Chou
President1.9yrsUS$1.45mpas de données
Edgar Cale
General Counsel & Company Secretary5yrsUS$804.69k0.080%
$ 31.7k
James Wilson
Co-Founder & Chief Scientific Advisorno datapas de donnéespas de données
Kathleen Borthwick
Senior VP1.2yrspas de données0.046%
$ 18.2k
Stuart Henderson
Senior Vice President of Corporate Development & Investor Relations3.6yrspas de donnéespas de données
Eden Fucci
Senior Vice President of Technical Operations1.2yrspas de donnéespas de données
Sue Browne
Senior Vice President of Research & Developmentless than a yearpas de donnéespas de données
Karl Whitney
Senior Vice President of Global Regulatory Affairsless than a yearpas de donnéespas de données

1.2yrs

Durée moyenne de l'emploi

55.5yo

Âge moyen

Gestion expérimentée: L'équipe de direction de PASG n'est pas considérée comme expérimentée (ancienneté moyenne 1.5 ans), ce qui suggère une nouvelle équipe.


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
William Chou
President1.9yrsUS$1.45mpas de données
Thomas Kassberg
Directorno datapas de donnéespas de données
Maxine Gowen
Independent Chairwoman of the Board3.6yrsUS$101.34k0%
$ 0
Saqib Islam
Independent Director5.5yrsUS$65.84k0.0081%
$ 3.2k
Athena Countouriotis
Independent Director4.6yrsUS$69.97k0.031%
$ 12.1k
Sandip Kapadia
Independent Director4.8yrsUS$73.34k0%
$ 0
Derrell Porter
Independent Director3.3yrsUS$69.30k0%
$ 0
Dolan Sondhi
Independent Director1.2yrsUS$49.90k0%
$ 0

3.5yrs

Durée moyenne de l'emploi

53.5yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de PASG sont considérés comme expérimentés (ancienneté moyenne 3.5 ans).